Home > ERS Monographs

Cardiovascular Complications of Respiratory Disorders

45.00
Product Code: ERM88-MEM-26041
  • On 1 July, ERS will resume sales of printed books within Europe. Unfortunately, intercontinental shipping remains disrupted. Electronic versions of many ERS books are available from our dedicated website at https://books.ersjournals.com/, or from Google Play Books, ebooks.com and the Amazon Kindle Store (in some territories), as well as from many library ebook vendors. For more information visit: https://books.ersjournals.com/ebooks-availability

    Expected shipping date: September 2020

    Edited by Miguel Ángel Martínez-García, Jean-Louis Pépin and Mario Cazzola
    This Monograph provides an update on cardiovascular disease complications and treatment implications for respiratory diseases, based on current scientific evidence and considered from an epidemiological, pathophysiological and clinical point of view. This book also discusses the true challenges when studying the complex relationship between these two groups of disorders.


    Contents list 
    1. Epidemiological aspects of cardiovascular and respiratory diseases
    2. Common pathophysiological pathways of the autonomic nervous system
    3. Murine models of cardiovascular damage in lung diseases

    Cardiovascular implications of specific respiratory disorders
    4. Cardiovascular disease in COPD
    5. Management of patients with asthma of COPD and cardiovascular disease: risks versus benefits
    6. Chronic asthma and the risk of cardiovascular disease
    7. Cardiovascular implications in bronchiectasis 
    8. Cardiovascular complications of cystic fibrosis
    9. Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment
    10. The heart in obesity hypoventilation syndrome
    11. Cardiovascular effects of innovative therapies in lung cancer
    12. Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
    13. Cardiovascular mortality and morbidity in pulmonary embolism
    14. The cardiovascular system in idiopathic pulmonary fibrosis
    15. Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections

    Cardiovascular risk of pulmonary pharmacology
    16. Beta2-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities
    17. Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists
    18. Impact of inhaled corticosteroids in patients with cardiovascular disease
    19. Cardiovascular side-effects of common antibiotics
    20. The cardiovascular effects of xanthines and selective PDE inhibitors: a risk–benefit analysis

    The Future
    21. Future challenges

    This book also includes clinical cases

    ISBN 978-1-84984-118-4

  • Delivery costs are calculated at the point of checkout.
      
    Orders are batched weekly and delivered from the UK.
    Delivery times (estimated) are as follows:
     
    Europe: 7-15 business days from date of despatch. 
    Rest of the World: 20-25 business days from date of despatch.
      
    Customers will be notified by email upon despatch.

Customer Reviews
Write an online review and share your thoughts with other shoppers!